NEW YORK--(BUSINESS WIRE)--Mercer, a global leader in unlocking real health and well-being and a business of Marsh McLennan (NYSE: MMC), today launched Mercer SelectRx, an exclusive product offering that leverages Free Market Health’s proprietary, cloud-based technology platform to drive competition among specialty pharmacies for high-cost specialty medications and savings for employers and their employees..

纽约-（商业新闻短讯）--Mercer是解锁真正健康和福祉的全球领导者，也是Marsh McLennan（纽约证券交易所：MMC）的一家公司，今天推出了Mercer SelectRx，这是一款利用自由市场健康专有技术的独家产品，基于云的技术平台，推动专业药店之间的竞争，为雇主及其员工节省高成本的专业药物。。

Prescription medications have been the fastest-growing component of employee health benefit costs for years, with specialty drugs rising by more than 10% in 2023, according to Mercer’s 2023 National Survey of Employer-Sponsored Health Plans. With an estimated 50 new specialty drugs entering the market annually including ultra-high-cost gene therapies, controlling drug costs will continue to be a challenge for employers and their employees..

多年来，处方药一直是员工健康福利成本增长最快的组成部分，根据美世2023年雇主赞助的健康计划全国调查，2023年特种药物增长超过10%。据估计，每年有50种新的专业药物进入市场，包括超高成本的基因疗法，控制药物成本将继续是雇主及其员工面临的挑战。。

Mercer SelectRx takes a novel approach to the current prescription drug supply chain model. Specialty prescriptions are directed to the platform, which drives competition among a curated network of specialty pharmacies with the right capabilities to service the employee. The pharmacy offering the lowest price on the approved specialty medication is chosen to dispense it, without any delays in the delivery of the medication to employees or impact to the drug rebates provided by pharmaceutical manufacturers to the employers..

Mercer SelectRx对当前的处方药供应链模型采取了一种新颖的方法。专业处方是针对平台的，这推动了具有适当能力为员工服务的专业药店策划网络之间的竞争。选择在批准的专业药物上提供最低价格的药房进行配药，不会延误向员工提供药物的时间，也不会影响制药商向雇主提供的药物回扣。。

While cost savings will vary by employer and prescribed medication, Mercer SelectRx could save employers and employees up to 10% off specialty drug spend.

虽然雇主和处方药的成本节约会有所不同，但美世SelectRx可以为雇主和员工节省高达10%的专业药物支出。

“Healthcare costs, particularly pharmacy benefit costs, are one of employers’ most unpredictable expenses year after year,” said Ed Lehman, US Health and Benefits Leader, Mercer. “We expect that Mercer SelectRx will deliver meaningful savings for employers and their employees while improving the employee experience.

“医疗保健费用，特别是药房福利费用，是雇主年复一年最不可预测的支出之一，”美国健康与福利领导者美世公司（Mercer）埃德·雷曼（EdLehman）表示。“我们预计，美世Select RX将为雇主及其员工带来有意义的节约，同时改善员工体验。

This solution is a win-win for our clients who are striving to support the health and wellness of their people and keep healthcare affordable.”.

对于我们的客户来说，这个解决方案是双赢的，他们正在努力支持他们的人民的健康和福祉，并保持医疗保健的价格。”。

Mercer SelectRx enables employees to have access to a broader network of quality specialty pharmacies, including those offering differentiated care models like integrated care and disease state specialization, without disrupting an employer’s relationship with its Pharmacy Benefit Manager (PBM). The tech-enabled model tracks each specialty claim to fulfillment, without disruption to the existing patient experience and with a reduction in employee abandonment of their medications..

Mercer SelectRx使员工能够访问更广泛的优质专业药店网络，包括那些提供差异化护理模式（如综合护理和疾病状态专业化）的药店，而不会破坏雇主与其药房福利经理（PBM）的关系。该技术支持的模型跟踪每个专业的实现要求，不会中断现有的患者体验，并减少员工放弃药物治疗。。

Alysha Fluno, pharmacist and National Pharmacy Practice Leader, Mercer said, 'Mercer SelectRx is one example of how we are working to expand healthcare access and affordability to employees on high-cost prescription medications. This innovative solution provides transparency on specialty pharmacy pricing – and ultimately, meaningful relief for employers and their employees struggling with the growing challenge of affording high-quality pharmaceutical care.'.

Mercer药剂师兼国家药房业务负责人Alysha Fluno说，“Mercer SelectRx是我们如何努力扩大员工对高成本处方药的医疗服务和负担能力的一个例子。这一创新的解决方案为专业药房定价提供了透明度，并最终为正在努力应对提供高质量药学服务这一日益严峻挑战的雇主及其员工提供了有意义的缓解。”。

Joe Cardosi, Founder and CEO of Free Market Health said, “Employers are increasingly asking for a new way to manage their specialty pharmacy spend while ensuring employees receive quality care. This strategic alliance with Mercer furthers our mission of efficiently delivering lower-cost, lifesaving, and life-altering medications into the hands of more patients across the country.”.

自由市场健康组织创始人兼首席执行官乔·卡多西（JoeCardosi）表示：“雇主越来越要求一种新的方法来管理他们的专业药房支出，同时确保员工获得优质护理。与美世的这一战略联盟进一步深化了我们的使命，即有效地将低成本、挽救生命和改变生命的药物提供给全国更多患者。”。

Click here for more information about Mercer SelectRx.

单击此处了解有关Mercer SelectRx的更多信息。

About Mercer

关于美世

Mercer believes in building brighter futures by redefining the world of work, reshaping retirement and investment outcomes, and unlocking real health and well-being. Mercer’s approximately 25,000 employees are based in 43 countries and the firm operates in over 130 countries. Mercer is a business of Marsh McLennan (NYSE: MMC), the world’s leading professional services firm in the areas of risk, strategy and people, with more than 85,000 colleagues and annual revenue of $23 billion.

美世认为，通过重新定义工作世界，重塑退休和投资成果，释放真正的健康和福祉，创造更光明的未来。美世在43个国家拥有约25000名员工，该公司在130多个国家开展业务。Mercer是Marsh McLennan（纽约证券交易所代码：MMC）的一家公司，该公司是全球领先的风险、战略和人力领域专业服务公司，拥有85000多名员工，年收入230亿美元。

Through its market-leading businesses including Marsh, Guy Carpenter and Oliver Wyman, Marsh McLennan helps clients navigate an increasingly dynamic and complex environment. For more information, visit mercer.com. Follow Mercer on LinkedIn and X..

马什·麦克伦南（Marsh McLennan）通过其市场领先的业务，包括马什（Marsh）、盖伊·卡彭特（Guy Carpenter）和奥利弗·怀曼（Oliver Wyman），帮助客户驾驭一个日益动态和复杂的环境。有关更多信息，请访问mercer.com。在LinkedIn和X上关注mercer。。

About Free Market Health

关于自由市场健康

Founded in 2019 and headquartered in Pittsburgh, Free Market Health partners with forward-thinking payers and specialty pharmacies of all sizes to streamline the complex and opaque specialty medication fulfillment process to ensure patients have prompt access to lifesaving and life-altering medications.

自由市场健康公司成立于2019年，总部位于匹兹堡，与具有前瞻性思维的付款人和各种规模的专业药店合作，简化复杂而不透明的专业药物履行流程，确保患者能够及时获得挽救生命和改变生命的药物。

Free Market Health opens up a dynamic, care-driven marketplace that empowers its stakeholders to optimize resources and maximize opportunities with the goal of balancing the cost of care and the value that care provides. The company is supported by Questa Capital, Alta Partners, Highmark Ventures, and 653 Investment Partners.

自由市场健康开辟了一个动态的、由护理驱动的市场，使其利益相关者能够优化资源并最大限度地利用机会，以平衡护理成本和护理提供的价值。该公司得到了Questa Capital、Alta Partners、Highmark Ventures和653个投资伙伴的支持。

Learn more at www.freemarkethealth.com..

Learn more at www.freemarkethealth.com..